Litigation Details for Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-04-07 |
Court | District Court, D. Delaware | Date Terminated | 2018-02-26 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 8,410,131; 8,436,010; 8,778,962; 9,006,224 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc.
Details for Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2018-02-25 | 14 | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,006,224; 8,410,131; 8,778,962; 8,436,010… 26 February 2018 1:17-cv-00393 830 Patent None District Court, D. Delaware | External link to document | |
2017-04-07 | 4 | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,006,224; 8,410,131; 8,778,962; 8,436,010… 26 February 2018 1:17-cv-00393 830 Patent None District Court, D. Delaware | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |